New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine 2.5%{relative} (plus additional 10% overage); prilocaine 2.5%{relative} (plus additional 10% overage) - topical cream - 5 % - active: lidocaine 2.5%{relative} (plus additional 10% overage) prilocaine 2.5%{relative} (plus additional 10% overage) excipient: carbomer polyoxyl 35 castor oil sodium hydroxide water for injection - topical anaesthesia of the skin prior to insertion of i.v. catheters, blood sampling, vaccination, superficial surgical procedures, including split skin grafting. topical anaesthesia of leg ulcers to facilitate mechanical cleansing or debridement. topical anaesthesia of the female genital mucosa and male genital skin, for example, prior to superficial surgical procedures or infiltration anaesthesia. topical anaesthesia of the skin prior to minor superficial cosmetic procedures.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lidocaine 2.5%; prilocaine 2.5% - dermal patch - active: lidocaine 2.5% prilocaine 2.5% excipient: carbomer polyoxyl 35 castor oil purified water sodium hydroxide - topical anaesthesia of the skin prior to insertion of i.v. catheters, blood sampling, vaccination, superficial surgical procedures, including split skin grafting.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - colchicine 0.5mg;   - tablet - 0.5 mg - active: colchicine 0.5mg   excipient: lactose monohydrate magnesium stearate maize starch povidone - treatment of acute gout. colchicine should not be used unless nsaids are contraindicated, or have been used and found to lack efficacy or to have unacceptable side effects in the individual patient.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - digoxin 0.25mg;  ;  ;  ;  ; digoxin 0.25mg - tablet - 0.25 mg - active: digoxin 0.25mg         excipient: lactose monohydrate magnesium stearate maize starch pregelatinised maize starch purified water rice starch active: digoxin 0.25mg excipient: lactose monohydrate magnesium stearate maize starch purified water rice starch starch, oxidised - cardiac failure:- lanoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. its therapeutic benefit is greatest in those patients with ventricular dilatation. lanoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation. supraventricular arrhythmias:- lanoxin is indicated in the management of certain supraventricular arrhythmias, particularly atrial flutter and fibrillation, where a major beneficial effect is reduction of the ventricular rate.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - digoxin 0.0625mg;  ;  ;  ;  ; digoxin 0.0625mg - tablet - 0.0625 mg - active: digoxin 0.0625mg         excipient: indigo carmine lactose monohydrate magnesium stearate maize starch povidone pregelatinised maize starch purified water rice starch active: digoxin 0.0625mg excipient: indigo carmine lactose monohydrate magnesium stearate maize starch povidone purified water rice starch starch, oxidised - cardiac failure:- lanoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. its therapeutic benefit is greatest in those patients with ventricular dilatation. lanoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation. supraventricular arrhythmias:- lanoxin is indicated in the management of certain supraventricular arrhythmias, particularly atrial flutter and fibrillation, where a major beneficial effect is reduction of the ventricular rate.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - gabapentin 100mg - capsule - 100 mg - active: gabapentin 100mg excipient: gelatin lactose monohydrate maize starch purified talc titanium dioxide - neurontin is indicated for the treatment of partial seizures with or without secondarily generalised tonic-clonic seizures, in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - gabapentin 300mg - capsule - 300 mg - active: gabapentin 300mg excipient: gelatin iron oxide yellow lactose monohydrate maize starch purified talc titanium dioxide - neurontin is indicated for the treatment of partial seizures with or without secondarily generalised tonic-clonic seizures, in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - gabapentin 400mg - capsule - 400 mg - active: gabapentin 400mg excipient: gelatin iron oxide red iron oxide yellow lactose monohydrate maize starch purified talc titanium dioxide - neurontin is indicated for the treatment of partial seizures with or without secondarily generalised tonic-clonic seizures, in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - gabapentin 600mg - film coated tablet - 600 mg - active: gabapentin 600mg excipient: candelilla wax crospovidone magnesium stearate maize starch nitrogen opadry white ys-1-18111 poloxamer 407 purified water - neurontin is indicated for the treatment of partial seizures with or without secondarily generalised tonic-clonic seizures, in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - gabapentin 800mg; gabapentin 800mg - film coated tablet - 800 mg - active: gabapentin 800mg excipient: candelilla wax crospovidone magnesium stearate maize starch nitrogen opacode orange ns-78-13026 opadry white ys-1-18111 poloxamer 407 purified water active: gabapentin 800mg excipient: candelilla wax crospovidone magnesium stearate maize starch nitrogen opadry white ys-1-18111 poloxamer 407 purified water - neurontin is indicated for the treatment of partial seizures with or without secondarily generalised tonic-clonic seizures, in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs